Cargando…
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
In this review, the potential future role of microRNA-based therapies and their specific application in lung diseases is reported with special attention to pulmonary hypertension. Current limitations of these therapies will be pointed out in order to address the challenges that they need to face to...
Autores principales: | Carregal-Romero, Susana, Fadón, Lucía, Berra, Edurne, Ruíz-Cabello, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246754/ https://www.ncbi.nlm.nih.gov/pubmed/32375361 http://dx.doi.org/10.3390/ijms21093253 |
Ejemplares similares
-
miRacle of microRNA-Driven Cancer Nanotherapeutics
por: Kara, Goknur, et al.
Publicado: (2022) -
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018) -
Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
por: Seshadri, Dhruv R., et al.
Publicado: (2018) -
Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021) -
Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension
por: Xiao, Tingting, et al.
Publicado: (2017)